SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-030298
Filing Date
2024-08-05
Accepted
2024-08-05 17:27:04
Documents
11

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 2997258
2 forms-1_001.jpg GRAPHIC 10244
3 form10-k_002.jpg GRAPHIC 119366
4 form10-k_003.jpg GRAPHIC 75749
5 form10-k_004.jpg GRAPHIC 59453
6 form10-k_005.jpg GRAPHIC 114184
7 form10-k_006.jpg GRAPHIC 121592
8 form10-k_007.jpg GRAPHIC 71159
9 form10-k_008.jpg GRAPHIC 26799
10 form10-k_009.jpg GRAPHIC 119739
11 form10-k_010.jpg GRAPHIC 55116
  Complete submission text file 0001493152-24-030298.txt   4064823
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280414 | Film No.: 241176167
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)